News

Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at hscora@ouhsc.edu so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

OUHSC Research News – Monday, May 23, 2022

OUHSC Research News – Monday, May 23, 2022

 

Notices and Reminders

SoonerTrack II Update

The Office of Research Administration (ORA) is pleased to announce that starting May 31, User Acceptance Testing (UAT) of SoonerTrack II, an improved version of SoonerTrack I, will begin with the department testers. The purpose of UAT is to allow the department testers to interact with the new forms, test the process, and provide any feedback for future improvements. We anticipate that the SoonerTrack II system will go live on July 5, 2022, replacing the SoonerTrack I system. We will keep you updated with additional details as the go-live date approaches. In the meantime, please check your current SoonerTrack tickets for any outstanding statuses that need to be completed/withdrawn prior to the go-live date.

If you have any questions, please contact soonertrackhelpdesk@ouhsc.edu.

 

Open Position: Core Director for OUHSC Shared Research Facilities: OUHSC invites applications for the position of Core Facilities Director. This position will work closely with the Associate Vice President for Health Sciences Research in charge of Research Resources (AVPHSR-RR) to oversee the daily Core operations, interact with Core customers, provide ongoing assessment and surveys of core impact and customer satisfaction, identify needs for new equipment/technologies, hire and manage Core personnel, and oversee budget and business plans.

For more information on the duties and essential competency requirements for this position, please refer to the attached flyer.

 

NIH Disclosures Guidance

As a reminder, NIH policy now requires applicants and awardees to disclose “all resources made available to a researcher in support of and/or related to all of their research endeavors, regardless of whether or not they have monetary value and regardless of whether they are based at the institution the researcher identifies for the current grant.”  Further details on what needs to be disclosed can be found on Notice NOT-OD-19-114.

If you are not sure whether a particular activity should be reported in the biosketch, other support, or annual project reports, check out  NIH Disclosures Table. This table provides a list of various activities and when they need to be disclosed.

 

Interested in becoming an IRB Member?

The OUHSC Institutional Review Board (IRB) currently has openings for new IRB members. The IRB reviews research proposals for human research projects to ensure that the rights and welfare of human participants are protected and that risk of harm is minimized.  The IRB is specifically looking for:

  • Non-scientific members of the community who are not affiliated with the University and can represent the perspective of participants
  • Healthcare providers with background in pharmacy, psychology, oncology or pediatric medicine.

To learn more about IRB membership and time commitments, please contact the HRPP Office at 405-271-2045 or email to hrpp@ouhsc.edu.

 

ORA Notice: CRIOC (Clinical Research Informatics Oversight Committee) Approval

ORA has stablished a process for actively managing requests to share health data with third parties. Regardless of whether or not human subjects are involved in research project, Principal Investigators (PIs) are required to answer the following questions. We are asking these questions manually until SoonerTrack II is up and running with the questions as part of the request form.

Please note that if OU Health patient data is being used, we cannot proceed with posting the Notice of Award (NOA) until the CRIOC approval is received.

  • Are you sharing any data that contains Protected Health Information (PHI), Personally Identifiable Information (PII), Limited Data Set (LDS), De-Identified, or Other?
    • If no, no further information necessary.
    • If yes, answer the following:
  • What type of data (please state PHI, PII, LDS, De-Identified, or Other; may be a combination)?
  • Does the data being shared come from OU Health patient data?
  • With respect to the data being shared, is OUHSC the Provider, Recipient, or Mutual?
  • Finally, please provide a description of the data being shared

 

OUHSC Funding Opportunities

Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  

  • Eurofarma, a Brazilian pharmaceutical company, is seeking validated targets, novel compounds, and/or adjuvant compounds for antibacterial drugs/therapies.  Highest priority given to small molecule bactericidal drugs with validated targets; gram-negative and ESKAPE pathogens are of particular interest.  Out of scope: compositions targeting mycobacteria.  Submission entails a 1-pg non-confidential summary of technology.  (deadline 06/06)
  • Grunenthal, a global leader in pain management, is seeking new chemical entities and novel targets (linked to nociceptive pathways) for treatment of pain in humans.  In scope:  compounds (modality agnostic) to provide pain relief in osteoarthritic pain, peripheral neuropathic pain, chronic low back pain and prevention of post-surgical chronic pain.  Out of Scope: targets related to opioids, local anesthetics or cannabinoid pathways of the NGF-pathway; cell therapies, re-purposed and re-formulated existing drugs.  Submission entails a 1-pg non-confidential summary of technology.  (deadline 06/12)
  • A plant breeding an biotechnology company (anonymous) is seeking solutions to allow indoor cultivation and crossing of soybeans within a 60-day lifecycle.  Of particular interest is growth regulators in combination with indoor breeding protocols to overcome flowering delay and speed lifecycle in tropical or subtropical varieties.  Submission entails a 1-pg non-confidential summary of technology.  (deadline 06/12)

 

 NIH Notices 

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

NIH Funding Opportunities

 

Other Funding Opportunities

The Cystic Fibrosis Foundation (CFF): Path to a Cure -- Collaborative Research Grant

Description: Path to a Cure: Collaborative Research Grants are intended to facilitate research that will contribute to the development of new therapies or therapeutic strategies to treat CF, with an emphasis on advancing CFTR gene repair and replacement approaches. Collaborations that bring new investigators and technologies into the CF research community will be given highest priority. Proposals must include preliminary data to justify support from the Cystic Fibrosis Foundation.

Application deadline: July 14, 2022

Link to Full Announcement: https://www.cff.org/researchers/path-cure-collaborative-research-grant

 

2022 Michelson Prizes: Next Generation Grants

Description: Next Generation Grants are $150,000 research grants given annually to support promising researchers who are applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research for major global diseases. The committee will be looking for research aimed at tackling the current roadblocks that exist in human vaccine development and expanding our limited understanding of key immune processes that are fundamental to successful vaccine and immunotherapy development. The Michelson Prizes are awarding research that is highly innovative and impactful, with the potential to be applied across many diseases.

Application deadline: June 26, 2022

Link to Full Announcement: https://www.humanvaccinesproject.org/michelson-prizes/

 

Health Resources and Services Administration (HRSA) Public Health Scholarship Program (PHSP)

Description: The purpose of the PHSP is to strengthen the public health workforce by providing support to organizations to develop scholarship programs that incentivize individuals to pursue training and careers in public health. Through the PHSP, scholarship recipients will gain the requisite knowledge and skills necessary to prevent, prepare for, and respond to recovery activities related to COVID–19, as well as other public health emergencies.

Application deadline: June 1, 2022

Link to Full Announcement: https://www.hrsa.gov/grants/find-funding/hrsa-22-122

 

The Vilcek Foundation 2023 Vilcek Prizes for Creative Promise in Biomedical Science

Description: The Vilcek Foundation will award three Creative Promise Prizes of $50,000 each to young, immigrant biomedical scientists who demonstrate outstanding early achievement. Applicants should have been born outside of the United States and be 38 years of age or younger, but limited exceptions to the age requirement will be granted to those who have taken time off for caregiving, medical, military, or parental leave. Three winners will each receive a $50,000 unrestricted cash prize and be honored at an awards ceremony in New York City in April 2023. 

Deadline: June 10, 2022

Link to Full Announcement: https://vilcek.org/prizes/vilcek-prizes-for-creative-promise/creative-promise-prizes-biomedical-science/

 

DoD FY22 Lupus Research Program (LRP)

  • Idea Award (IA)
  • Impact Award (IPA)
  • Transformative Vision Award (TVA)

Pre-Application (Letter of Intent): August 16, 2022
Application: September 1, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/lrp

 

DoD FY22 Vision Research Program (VRP)

  • Clinical Trial Award (CTA)
  • Focused Translational Team Science Award (FTTSA)
  • Investigator-Initiated Research Award (IIRA)
  • Translational Research Award (TRA)

Pre-Application (Preproposal): July 15, 2022
Application: November 9, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/vrp

 

DoD FY22 Rare Cancers Research Program (RCRP)

  • Concept Award (CA)
  • Idea Development Award (IDA)
  • Resource and Community Development Award (RCDA)

Pre-Application (Letter of Intent): July 18, 2022
Application: August 29, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/rcrp

 

DoD FY22 Pancreatic Cancer Research Program (PCARP)

  • Idea Development Award (IDA)
  • Translational Research Partnership Award (TRPA)

Pre-Application (Preproposal): July 8, 2022 
Application: October 6, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/pcarp

 

DoD FY22 Multiple Sclerosis Research Program (MSRP)

  • Clinical Trial Award (CTA)
  • Early Investigator Research Award (EIRA)
  • Exploration - Hypothesis Development Award (EHDA)
  • Investigator-Initiated Research Award (IIRA)

Pre-Application (Preproposal): June 23, 2022

Application: October 3, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/msrp

 

DoD FY22 Bone Marrow Failure Research Program (BMFRP)

  • Idea Development Award (IDA)
  • Investigator-Initiated Research Award (IIRA)

Pre-Application (Preproposal): June 29, 2022

Application: September 23, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/bmfrp

 

DoD FY22 Prostate Cancer Research Program (PCRP)

  • Exploration – Hypothesis Development Award (EHDA)

Pre-Application (Letter of Intent [LOI]): June 2, 2022

Application: June 23, 2022

  • Early Investigator Research Award (EIRA)
  • Physician Research Award (PRA)

Pre-Application (LOI): July 7, 2022

Application: July 28, 2022

Letters of Recommendation: August 2, 2022

  • Translational Science Award (TSA)
  • Health Disparity Research Award (HDRA)
  • Data Science Award (DSA)

Pre-Application (LOI): August 4, 2022

Application: August 25, 2022

  • Idea Development Award (IDA)

Pre-Application (LOI): July 7, 2022

Application: July 28, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/pcrp

 

DoD FY22 Peer Reviewed Orthopaedic Research Program (PRORP)

  • Applied Research Award (ARA)
  • Clinical Trial Award (CTA)
  • Clinical Translational Research Award (CTRA)

Pre-Application (Preproposal): June 16, 2022
Application: September 13, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/prorp

 

DoD FY22 Peer Reviewed Cancer Research Program (PRCRP)

  • Behavioral Health Science Award (BHSA)
  • Career Development Award (CDA) – Fellow Option
  • Career Development Award (CDA) – Virtual Cancer Center Scholar Option
  • Translational Team Science Award (TTSA)

Pre-Application (Letter of Intent): July 12, 2022

Application: August 2, 2022

  • Convergent Science Cancer Consortium Development Award (CSCCDA)

Pre-Application (Letter of Intent): August 17

Application: September 7, 2022

  • Idea Award (IA)
  • Impact Award (IPA)

Pre-Application (Preproposal): May 25, 2022

Invitation to Submit: July 11, 2022

Application: September 7, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/prcrp

 

DoD FY22 Lung Cancer Research Program (LCRP)

  • Clinical Translational Research Partnership Award (CTRPA)        

Pre-Application (Letter of Intent): July 13, 2022

Letter of Intent is required.

Application: July 27, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/lcrp

 

Robert Wood Johnson Foundation Funding Opportunities

The Robert Wood Johnson Foundation funds a wide array of research and initiatives to help address some of America’s most pressing health challenges.

Evidence for Action prioritizes research to evaluate specific interventions that have the potential to contribute to dismantling and counteracting the harms of structural and systemic racism and improving health, well-being, and equity outcomes.

Application Due Date: Proposals will be accepted throughout the year on a rolling admission

Pioneering Ideas: Exploring the Future to Build a Culture of Health welcomes proposals that are primed to influence health equity in the future.

Application Due Date: Proposals will be accepted throughout the year on a rolling admission

Link to Full Announcement: https://www.rwjf.org/en/how-we-work/grants-explorer/funding-opportunities.html

 

 

Print

Documents to download